Clinical Trials Browser

Phase 1 × ALX148 × Other hematologic neoplasm × Clear all

NCT04755244 2024-11-27

A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute